Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aldosterone in myxoedema

P Marks, J Anderson, R Vincent

    Lancet (London, England)
    |December 16, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Thyroxine treatment for severe myxedema (underactive thyroid) increased aldosterone levels. High aldosterone in two patients led to cardiac failure, which resolved upon reducing thyroxine dosage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Meta-analysis for descriptive research.

    Research in nursing & health·1992
    Same author

    Oxygen-induced lung damage. Relationship to lung mitochondrial glutathione levels.

    The American review of respiratory disease·1992
    Same author

    Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.

    Cancer·1992
    Same author

    Effects of verapamil on the acute toxicity of doxorubicin in vivo.

    Journal of the National Cancer Institute·1992
    Same author

    Hypothesis for the control of clotting factor VIII inhibitory antibodies by decreasing potency of helper T-cell-recognized epitopes in factor VIII.

    Scandinavian journal of immunology·1992
    Same author

    Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.

    Experimental hematology·1992

    Area of Science:

    • Endocrinology
    • Cardiology

    Background:

    • Myxedema, a severe form of hypothyroidism, requires careful management.
    • Thyroid hormone replacement therapy is standard treatment for hypothyroidism.

    Purpose of the Study:

    • To investigate the effect of thyroxine dosage on aldosterone levels in patients with severe myxedema.
    • To assess the clinical implications of altered aldosterone levels during thyroid hormone replacement therapy.

    Main Methods:

    • Ten patients with severe myxedema were enrolled.
    • Thyroxine dosage was gradually increased in all patients.
    • Urine aldosterone excretion and plasma-aldosterone levels were monitored.
    • Cardiac function and clinical status were assessed.

    Main Results:

    Related Experiment Videos

    • Thyroxine administration led to a dose-dependent increase in both urine aldosterone excretion and plasma-aldosterone levels.
    • Two patients experienced abnormally high serum-aldosterone levels.
    • These two patients developed cardiac failure, which resolved upon reduction of the thyroxine dose.

    Conclusions:

    • Thyroxine replacement therapy can significantly impact aldosterone levels in patients with severe myxedema.
    • Elevated aldosterone levels secondary to thyroxine treatment may contribute to cardiac complications.
    • Careful monitoring and dose adjustment of thyroxine are crucial in managing patients with myxedema, particularly regarding cardiovascular risks.